Press Releases
Conference speakers, exhibitors, sponsors and delegates may request that we place links to their press releases here as we approach the conference.Read Recent Press Releases
Articles in the Press mentioning BioTrinity 2007
A Capital Adventure Oxford Times "In Business", Bioline, 21st September 2007
Drug firm seeks new identity Oxford Mail, Tuesday 27th March 2007
Cobra: 'process development is the key' Process development is the key when outsourcing clinical supply biomanufacturing to a contractor, according to an industry player. BioPharma Reporter, 29th March 2007
Phynova - Significant progress in product pipeline OBN, Monday 02 April 2007
US equity market potential goldmine for biotech companies. The US equity market is open to biotech companies and it is a good time for them to raise money, delegates heard at Biotrinity in Oxfordshire, UK. 10/04/2007 BioPharma Reporter.
Attracting big pharma's attention Pfizer has given an insight into what it is about smaller companies that makes the world's largest pharma company want to buy them. Drug Researcher, 12th April 2007
Now is an ideal time for small biotechs to ink that perfect deal with big pharma, attendees heard at the recently held Biotrinity conference in Oxfordshire, UK. BioPharma Reporter, 12th April 2007
Among our recent registrants, see who else has signed up!
VP Licensing, Shire Pharma
Principal (Life Sciences), Atlas Venture
Investment Director, Oxford Capital Partners
CEO, Solace Pharma
CEO, Glide Pharma
CEO, Chemocentryx
CEO, Celleron Therapeutics
CEO, Phynova
EVP Business Development, Evotec
CEO, Hybrid Systems
CEO, Summit plc
CEO, (OSI) Prosidion
CEO, Oxford Genome Sciences
Business Research and Development Manager, Biocompatibles
Submit your email address to receive conference updates
PROJECT PARTNERS
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
